Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome

被引:6
作者
Ji, Ying [1 ]
Wang, Yan-Li [2 ]
Xu, Fang [1 ]
Jia, Xi-Bei [1 ]
Mu, Su-Hong [1 ]
Lyu, Hui-Yan [1 ]
Yuan, Xue-Ying [1 ]
Na, Shi-Ping [1 ]
Bao, Yu-Shi [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Nephrol, 23 Youzheng St, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Rheumatol, Harbin, Peoples R China
关键词
podoplanin; C-type lectin-like receptor 2; nephrotic syndrome; hypercoagulable state; thrombosis; VENOUS THROMBOSIS; TUMOR-METASTASIS; RECEPTOR CLEC-2; THROMBOEMBOLISM; PLATELETS; INTEGRITY; ROLES; MICE;
D O I
10.1177/10760296221108967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Podoplanin (PDPN) promotes platelet aggregation and activation by interacting with C-type lectin-like receptor 2(CLEC-2) on platelets. The interaction between the upregulated PDPN and platelet CLEC-2 stimulates venous thrombosis. PDPN was identified as a risk factor for coagulation and thrombosis in inflammatory processes. Hypercoagulability is defined as the tendency to develop thrombosis according to fibrinogen and/or D dimer levels. Nephrotic syndrome is also considered to be a hypercoagulable state. The aim of this study is to investigate the association of soluble PDPN/CLEC-2 with hypercoagulability in nephrotic syndrome. Thirty-five patients with nephrotic syndrome and twenty-seven healthy volunteers were enrolled. PDPN, CLEC-2 and GPVI concentrations were tested by enzyme-linked immunosorbent assay (ELISA). Patients with nephrotic syndrome showed higher serum levels of PDPN and GPVI in comparison to healthy controls (P < .001, P = .001). PDPN levels in patients with nephrotic syndrome were significantly correlated with GPVI (r = 0.311; P = .025), hypoalbuminemia (r = -0.735; P < .001), hypercholesterolemia (r = 0.665; P < .001), hypertriglyceridemia (r = 0.618; P < .001), fibrinogen (r = 0.606; P < .001) and D-dimer (r = 0.524; P < .001). Area under the curve (AUC) for the prediction of hypercoagulability in nephrotic syndrome using PDPN was 0.886 (95% CI 0.804-0.967, P < .001). Cut-off value for the risk probability was 5.88 ng/ml. The sensitivity of PDPN in predicting hypercoagulability was 0.806, and the specificity was 0.846. When serum PDPN was >5.88 ng/ml, the risk of hypercoagulability was significantly increased in nephrotic syndrome (OR = 22.79, 95% CI 5.92-87.69, P < .001). In conclusion, soluble PDPN levels were correlated with hypercoagulability in nephrotic syndrome. PDPN has the better predictive value of hypercoagulability in nephrotic syndrome as well as was a reliable indicator of hypercoagulable state.
引用
收藏
页数:7
相关论文
共 31 条
[1]  
Al-Azzawi Hasan F, 2016, Int J Crit Illn Inj Sci, V6, P85, DOI 10.4103/2229-5151.183019
[2]   Targeting GPVI as a novel antithrombotic strategy [J].
Andrews, Robert K. ;
Arthur, Jane F. ;
Gardiner, Elizabeth E. .
JOURNAL OF BLOOD MEDICINE, 2014, 5 :59-68
[3]   Thrombosis in Nephrotic Syndrome [J].
Barbano, Biagio ;
Gigante, Antonietta ;
Amoroso, Antonio ;
Cianci, Rosario .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (05) :469-476
[4]   Podoplanin expression on endothelial cells promotes superficial erosive injury and thrombus formation in rat carotid artery: Implications for plaque erosion [J].
Furukoji, Eiji ;
Yamashita, Atsushi ;
Nakamura, Kensuke ;
Hirai, Toshinori ;
Asada, Yujiro .
THROMBOSIS RESEARCH, 2019, 183 :76-79
[5]  
Group KDIGOKCW., 2013, KIDNEY INT SUPPL, V3, P1
[6]   Thrombophilia and Hypercoagulability [J].
Hassouna, Houria I. .
MEDICAL PRINCIPLES AND PRACTICE, 2009, 18 (06) :429-440
[7]   Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2 [J].
Herzog, Brett H. ;
Fu, Jianxin ;
Wilson, Stephen J. ;
Hess, Paul R. ;
Sen, Aslihan ;
McDaniel, J. Michael ;
Pan, Yanfang ;
Sheng, Minjia ;
Yago, Tadayuki ;
Silasi-Mansat, Robert ;
McGee, Samuel ;
May, Frauke ;
Nieswandt, Bernhard ;
Morris, Andrew J. ;
Lupu, Florea ;
Coughlin, Shaun R. ;
McEver, Rodger P. ;
Chen, Hong ;
Kahn, Mark L. ;
Xia, Lijun .
NATURE, 2013, 502 (7469) :105-+
[8]   Splanchnic venous thrombosis in a nephrotic patient following COVID-19 infection: a case report [J].
Hussein, Maged H. ;
Alabdaljabar, Mohamad S. ;
Alfagyh, Noorah ;
Badran, Mohammad ;
Alamiri, Khalid .
BMC NEPHROLOGY, 2021, 22 (01)
[9]   Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis [J].
Inoue, Osamu ;
Hokamura, Kazuya ;
Shirai, Toshiaki ;
Osada, Makoto ;
Tsukiji, Nagaharu ;
Hatakeyama, Kinta ;
Umemura, Kazuo ;
Asada, Yujiro ;
Suzuki-Inoue, Katsue ;
Ozaki, Yukio .
PLOS ONE, 2015, 10 (09)
[10]   Epidemiology and Pathophysiology of Nephrotic Syndrome-Associated Thromboembolic Disease [J].
Kerlin, Bryce A. ;
Ayoob, Rose ;
Smoyer, William E. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (03) :513-520